US FDA grants Argenica Orphan Drug designation to treat ‘devastating condition’ in newborns
US FDA grants ARG-007 orphan drug designation to treat hypoxic ischaemic encephalopathy No therapeutic drug on the market to protect brain cells following hypoxic ischaemic [more…]
Thick, shallow and high grade: Azure’s Target Area 3 at Andover is jam-packed with lithium
Over 500m of thick, high-grade lithium is confirmed at the APOOO3/APOOO4 pegmatite over 500m strike >1km and 450m of down-dip visual spodumene observed at the [more…]
High demand means Ionic Rare Earths magnet recycling demo plant will soon operate around the clock
Ionic Rare Earths’ magnet recycling demonstration plant is ramping up to move to 24/7 continuous operation from early January 2024 This is a result of [more…]
PETER STRACHAN: REE prices are rising again, but who’s winning the ASX race to production?
Peter Strachan is a capital markets veteran, resources analyst and lover of the oil and gas game. The brains behind the popular weekly StockAnalysis investment [more…]
Dr Boreham’s Crucible: Nanosonics is testing more patience than ever. Is it a case of ‘relax and it won’t hurt a bit’?
Reflecting on his 10 years as CEO of the medical device play – a milestone achieved last month – Michael Kavanagh says the numbers tell [more…]
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
Xi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at [more…]
High Voltage: Exxon lithium pivot to push lithium narrative into overdrive; EV sales surge in Europe
Oil and gas titan ExxonMobil reveals big bold lithium-producing plans Despite recent bearish lithium spot prices, EV sales are surging in Europe S&P Global believes [more…]
Kyle on Capital: Three easy ASX picks for when you finally yield to Mr Bond
Cyclicals look sickly. Copper’s come a cropper and – most importantly – surging global bond yields are showing signs of fatigue. Stories drive markets, writes [more…]
Argonaut says it keeps getting harder to build a new project – but rates these 11 developers to get it done
Argonaut has named its 11 best undeveloped mining projects held by Australian companies in 2023 It comes as development timeframes blow out, threatening the next [more…]
Rise and Shine: Everything you need to know before the ASX opens-330
Good morning everyone, and welcome to Thursday, 16 November – a date on the Great Musical Calendar that will forever be remembered as the day [more…]
